Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03661281 · ClinicalTrials.gov registry record · NA
Function Following Thumb MP Fusion and IP Fusion
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT03661281: Completed NA study, sponsored by NYU Langone Health.
NCT03661281 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03661281, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
This study is to determine function following simulated thumb metacarpophalangeal (MP) and thumb interphalangeal (IP) joint fusion. The investigators want to determine the functional limitation created by MP and IP joint fusion. 20-30 volunteers will be fitted for custom molded orthoplast splints immobilizing either the MP or IP joint. The volunteers will then be taken through multiple tests including lateral pinch strength, tip pinch, grip strength, grooved pegboard test time, and Jebson Taylor test. Each patient will be tested without a splint, with their MP joint immobilized and with their IP joint immobilized. The results of this study can be used for patient education before surgery in order to help them make informed decisions as well as manage expectations. It can also serve as a decision aid in pinch restoration in the context of ulnar nerve palsy.
Primary Outcome
This consists of seven test items, which are felt to represent various hand activities. Each activity will be timed.
Interventions
- DIAGNOSTIC_TEST Jebsen Taylor Hand function test
- DIAGNOSTIC_TEST Pinch strength
- DIAGNOSTIC_TEST Grooved pegboard test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2018-02-01 |
| Est. Completion | 2019-06-24 |
| Phase | NA |
What the finished NCT03661281 record still lists
NCT03661281 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Jebsen Taylor Hand function test is the first listed.
NCT03661281 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03661281 about?
NCT03661281 is a clinical study titled "Function Following Thumb MP Fusion and IP Fusion". This study is to determine function following simulated thumb metacarpophalangeal (MP) and thumb interphalangeal (IP) joint fusion. The investigators want to determine the functional limitation created by MP and IP joint fusion. 20-30 volunteers will be fitted for custom molded orthoplast splints im...
What is the current status of trial NCT03661281?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2018-02-01. Estimated completion is 2019-06-24.
What interventions are being tested in trial NCT03661281?
The interventions under investigation include: Jebsen Taylor Hand function test (DIAGNOSTIC_TEST), Pinch strength (DIAGNOSTIC_TEST), Grooved pegboard test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03661281?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03661281's enrollment target sits among peer trials
32 1578th of 2000 higher than 409 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI